Neon Therapeutics Inc (NTGN):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Neon Therapeutics Inc (NTGN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8152
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Neon Therapeutics Inc (Neon Therapeutics) is a clinical-stage immuno-oncology company that focuses on the development of neoantigen-based therapeutics for the treatment of cancer. The company pipeline product portfolio comprises NEO-PV-01, a personal neoantigen vaccine; NEO-PTC-01, a personal neoantigen T cell therapy; and NEO-SV-01, a breast neoantigen vaccine among others. Neon Therapeutics is headquartered in Cambridge, Massachusetts, the US.

Neon Therapeutics Inc (NTGN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Neon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Neon Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Neon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Neon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Neon Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10
Neon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Neon Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Neon Therapeutics Raises Additional USD36 Million in Series B Financing 13
Neon Therapeutics Raises USD70 Million in Series B Financing 15
Neon Therapeutics Raises USD55 Million in Series A Venture Financing 17
Partnerships 18
Natera Enters into Research Agreement with Neon Therapeutics 18
Neon Therapeutics Enters into Agreement with Merck 19
Neon Therapeutics Enters into Agreement with Apexigen 20
CRISPR Therapeutics and Neon Therapeutics Enter into Research Agreement 21
Vedantra Pharma Extends Research Agreement with Neon Therapeutics 22
Neon Therapeutics Enters into Research Agreement with Netherlands Cancer Institute 23
Neon Therapeutics Enters into Agreement with Bristol-Myers Squibb 24
Licensing Agreements 25
Neon Therapeutics Enters into Licensing Agreement with Netherlands Cancer Institute 25
Neon Therapeutics Enters into Licensing Agreement with Sanquin Blood Supply Foundation 26
Neon Therapeutics Enters into Licensing Agreement with Broad Institute, Dana-Farber Cancer Institute and Massachusetts General Hospital 27
Equity Offering 28
Neon Therapeutics Raises USD100 Million in IPO of Shares 28
Neon Therapeutics Inc – Key Competitors 30
Neon Therapeutics Inc – Key Employees 31
Neon Therapeutics Inc – Locations And Subsidiaries 32
Head Office 32
Recent Developments 33
Financial Announcements 33
Aug 06, 2018: Neon Therapeutics reports second quarter 2018 financial results and recent business highlights 33
Corporate Communications 35
Dec 12, 2017: Neon Therapeutics Expands Board of Directors with Leading Experts in Cancer Drug Discovery and Corporate Finance 35
Jun 16, 2017: Dr. Yasir Al-Wakeel Joins Neon Therapeutics as Chief Financial Officer 36
Product News 37
Jul 05, 2017: Initial Results from Dana-Farber Cancer Institute Personalized Neoantigen Vaccine Published in Nature 37
07/05/2017: Personal neoantigen vaccine prompts strong anti-tumor response in patients, study showsx 38
Feb 21, 2017: Using Mono-Allelic Mass Spectrometry Data to Improve Epitope Prediction Algorithms Published in Immunity 40
Clinical Trials 41
May 08, 2018: Neon Therapeutics Announces First Patient Treated in Clinical Trial Evaluating Personal Cancer Vaccine NEO-PV-01 in Combination with KEYTRUDA (pembrolizumab) and Chemotherapy 41
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42

List of Tables
Neon Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Neon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Neon Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Neon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Neon Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Neon Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10
Neon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Neon Therapeutics Raises Additional USD36 Million in Series B Financing 13
Neon Therapeutics Raises USD70 Million in Series B Financing 15
Neon Therapeutics Raises USD55 Million in Series A Venture Financing 17
Natera Enters into Research Agreement with Neon Therapeutics 18
Neon Therapeutics Enters into Agreement with Merck 19
Neon Therapeutics Enters into Agreement with Apexigen 20
CRISPR Therapeutics and Neon Therapeutics Enter into Research Agreement 21
Vedantra Pharma Extends Research Agreement with Neon Therapeutics 22
Neon Therapeutics Enters into Research Agreement with Netherlands Cancer Institute 23
Neon Therapeutics Enters into Agreement with Bristol-Myers Squibb 24
Neon Therapeutics Enters into Licensing Agreement with Netherlands Cancer Institute 25
Neon Therapeutics Enters into Licensing Agreement with Sanquin Blood Supply Foundation 26
Neon Therapeutics Enters into Licensing Agreement with Broad Institute, Dana-Farber Cancer Institute and Massachusetts General Hospital 27
Neon Therapeutics Raises USD100 Million in IPO of Shares 28
Neon Therapeutics Inc, Key Competitors 30
Neon Therapeutics Inc, Key Employees 31

List of Figures
Neon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Neon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Neon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Neon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Neon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Neon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Neon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Neon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Neon Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Neon Therapeutics Inc (NTGN):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bailian Group Co Ltd:企業の戦略的SWOT分析
    Bailian Group Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Nikkiso Co Ltd (6376):企業の財務・戦略的SWOT分析
    Nikkiso Co Ltd (6376) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Youlchon Chemical Co Ltd:企業の戦略・SWOT・財務情報
    Youlchon Chemical Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Youlchon Chemical Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Belk Inc:企業の戦略・SWOT・財務分析
    Belk Inc - Strategy, SWOT and Corporate Finance Report Summary Belk Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • American Midstream Partners LP (AMID):石油・ガス:M&Aディール及び事業提携情報
    Summary American Midstream Partners LP (American Midstream) is an oil and gas company that owns, operates, develops and acquires a diversified portfolio of midstream energy assets. The company’s services include processing, gathering, treating, and transporting of natural gas, fractionating NGLs and …
  • PolyNovo Ltd (PNV):企業の財務・戦略的SWOT分析
    Summary PolyNovo Ltd (PolyNovo), formerly Calzada Ltd, is a medical device company that develops, manufactures and commercializes biodegradable polymers for use in medical devices. The company provides products such as biodegradable temporizing matrix and negative pressure wound therapy dressing sys …
  • Varian Medical Systems, Inc.:戦略・SWOT・企業財務分析
    Varian Medical Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Varian Medical Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • CCA Industries, Inc.:企業の戦略・SWOT・財務情報
    CCA Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary CCA Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • LifeWatch AG (LIFE)-医療機器分野:企業M&A・提携分析
    Summary LifeWatch AG (LifeWatch) is a healthcare technology and solutions company. It provides monitoring services and develops, manufactures, and markets advanced telehealth systems for high-risk and chronically ill patients. The company’s major services include mobile cardiac telemetry service, st …
  • Alion Science and Technology Corporation:戦略・SWOT・企業財務分析
    Alion Science and Technology Corporation - Strategy, SWOT and Corporate Finance Report Summary Alion Science and Technology Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Cyanotech Corp:企業の戦略・SWOT・財務分析
    Cyanotech Corp - Strategy, SWOT and Corporate Finance Report Summary Cyanotech Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • UCB SA (UCB):製薬・医療:M&Aディール及び事業提携情報
    Summary UCB SA (UCB) is a biopharmaceutical company that discovers and develops novel medicines and solutions to help treat various diseases. It principally focuses on developing products for the treatment of central nervous system (CNS) and immunology related conditions. The company's key medicines …
  • Guangzhou Improve Medical Instruments Co Ltd (300030):医療機器:M&Aディール及び事業提携情報
    Summary Guangzhou Improve Medical Instruments Co Ltd (Improve Medical) is a medical devices company that offers medical products, technologies, and services for clinical laboratory and clinical nursing. The company’s products include Improvacuter evacuated blood collection systems, Impromini capilla …
  • The Seibels Bruce Group Inc:企業の戦略・SWOT・財務分析
    The Seibels Bruce Group Inc - Strategy, SWOT and Corporate Finance Report Summary The Seibels Bruce Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • BDO International Limited:戦略・SWOT・企業財務分析
    BDO International Limited - Strategy, SWOT and Corporate Finance Report Summary BDO International Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • JSS Medical Research Inc-製薬・医療分野:企業M&A・提携分析
    Summary JSS Medical Research Inc (JSS) is a contract research organization which offers clinical research services. It provides clinical trial services in various therapeutic areas that include cardiovascular disorders, oncology, infectious disease, neurology and psychiatry, autoimmune disorders, re …
  • Ark Restaurants Corp. (ARKR):企業の財務・戦略的SWOT分析
    Ark Restaurants Corp. (ARKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Altria Group Inc (MO):企業の財務・戦略的SWOT分析
    Altria Group Inc (MO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Continental Engineering Corporation:企業の戦略・SWOT・財務情報
    Continental Engineering Corporation - Strategy, SWOT and Corporate Finance Report Summary Continental Engineering Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Australian Postal Corporation:企業の戦略・SWOT・財務情報
    Australian Postal Corporation - Strategy, SWOT and Corporate Finance Report Summary Australian Postal Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆